Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

1OB1

Crystal structure of a Fab complex whith Plasmodium falciparum MSP1-19

Summary for 1OB1
Entry DOI10.2210/pdb1ob1/pdb
DescriptorANTIBODY, HEAVY CHAIN, ANTIBODY, LIGHT CHAIN, MAJOR MEROZOITE SURFACE PROTEIN, ... (4 entities in total)
Functional Keywordsimmune system, immunoglobulin-complex, immunoglobulin, antibody fab fragment, msp1-19, egf-like domain, surface antigen, malaria vaccine component
Biological sourcePLASMODIUM FALCIPARUM
More
Total number of polymer chains6
Total formula weight117263.88
Authors
Pizarro, J.C.,Chitarra, V.,Verger, D.,Holm, I.,Petres, S.,Dartville, S.,Nato, F.,Longacre, S.,Bentley, G.A. (deposition date: 2003-01-22, release date: 2003-05-01, Last modification date: 2024-10-23)
Primary citationPizarro, J.C.,Chitarra, V.,Verger, D.,Holm, I.,Petres, S.,Dartville, S.,Nato, F.,Longacre, S.,Bentley, G.A.
Crystal Structure of a Fab Complex Formed with Pfmsp1-19, the C-Terminal Fragment of Merozoite Surface Protein 1 from Plasmodium Falciparum: A Malaria Vaccine Candidate
J.Mol.Biol., 328:1091-, 2003
Cited by
PubMed Abstract: Merozoite surface protein 1 (MSP1) is the major protein component on the surface of the merozoite, the erythrocyte-invasive form of the malaria parasite Plasmodium. Present in all species of Plasmodium, it undergoes two distinct proteolytic maturation steps during the course of merozoite development that are essential for invasion of the erythrocyte. Antibodies specific for the C-terminal maturation product, MSP1-19, can inhibit erythrocyte invasion and parasite growth. This polypeptide is therefore considered to be one of the more promising malaria vaccine candidates. We describe here the crystal structure of recombinant MSP1-19 from P.falciparum (PfMSP1-19), the most virulent species of the parasite in humans, as a complex with the Fab fragment of the monoclonal antibody G17.12. This antibody recognises a discontinuous epitope comprising 13 residues on the first epidermal growth factor (EGF)-like domain of PfMSP1-19. Although G17.12 was raised against the recombinant antigen expressed in an insect cell/baculovirus system, it binds uniformly to the surface of merozoites from the late schizont stage, showing that the cognate epitope is exposed on the naturally occurring MSP1 polypeptide complex. Although the epitope includes residues that have been mapped to regions recognised by invasion-inhibiting antibodies studied by other workers, G17.12 does not inhibit erythrocyte invasion or MSP1 processing.
PubMed: 12729744
DOI: 10.1016/S0022-2836(03)00376-0
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.9 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon